BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22069486)

  • 1. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
    Kato I; Niwa A; Heike T; Fujino H; Saito MK; Umeda K; Hiramatsu H; Ito M; Morita M; Nishinaka Y; Adachi S; Ishikawa F; Nakahata T
    PLoS One; 2011; 6(11):e27042. PubMed ID: 22069486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
    Kawaguchi A; Orba Y; Kimura T; Iha H; Ogata M; Tsuji T; Ainai A; Sata T; Okamoto T; Hall WW; Sawa H; Hasegawa H
    Blood; 2009 Oct; 114(14):2961-8. PubMed ID: 19657116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
    Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
    Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Level of SDF-1/CXCR4 in children with acute leukemia and its significance].
    Wen Q; Chen RL; Cai KR; Lin YW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):324-6. PubMed ID: 21518481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
    Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
    Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
    Tavor S; Petit I
    Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
    Zhang Y; Patel S; Abdelouahab H; Wittner M; Willekens C; Shen S; Betems A; Joulin V; Opolon P; Bawa O; Pasquier F; Ito M; Fujii N; Gonin P; Solary E; Vainchenker W; Coppo P; De Botton S; Louache F
    Cell Death Dis; 2012 Oct; 3(10):e396. PubMed ID: 23034331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
    Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
    J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
    Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of SDF-1alpha and its receptor CXCR4 in acute leukemias and their relationship with extramedullary infiltration].
    Liu ZR; Sun H; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):1-5. PubMed ID: 16584580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
    Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
    Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.
    Price TT; Burness ML; Sivan A; Warner MJ; Cheng R; Lee CH; Olivere L; Comatas K; Magnani J; Kim Lyerly H; Cheng Q; McCall CM; Sipkins DA
    Sci Transl Med; 2016 May; 8(340):340ra73. PubMed ID: 27225183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment.
    Skroblyn T; Joedicke JJ; Pfau M; Krüger K; Bourquin JP; Izraeli S; Eckert C; Höpken UE
    J Pathol; 2022 Sep; 258(1):12-25. PubMed ID: 35522562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
    Wilson GC; Freeman CM; Kuethe JW; Quillin RC; Nojima H; Schuster R; Blanchard J; Edwards MJ; Caldwell CC; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(8):G702-9. PubMed ID: 25721302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis.
    de Rooij B; Polak R; van den Berk LCJ; Stalpers F; Pieters R; den Boer ML
    Haematologica; 2017 Oct; 102(10):e389-e393. PubMed ID: 28619846
    [No Abstract]   [Full Text] [Related]  

  • 17. Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis.
    Mendt M; Cardier JE
    Stem Cells Dev; 2012 Aug; 21(12):2142-51. PubMed ID: 22121892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
    Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.